iRhythm Technologies Inc (IRTC) - Total Assets
Based on the latest financial reports, iRhythm Technologies Inc (IRTC) holds total assets worth $1.01 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of iRhythm Technologies Inc to assess how comfortably operating cash covers total debt obligations.
iRhythm Technologies Inc - Total Assets Trend (2013–2025)
This chart illustrates how iRhythm Technologies Inc's total assets have evolved over time, based on quarterly financial data. See iRhythm Technologies Inc shareholders equity for net asset value and shareholders' equity analysis.
iRhythm Technologies Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
iRhythm Technologies Inc's total assets of $1.01 Billion consist of 68.9% current assets and 31.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 23.1% |
| Accounts Receivable | $75.71 Million | 7.4% |
| Inventory | $21.63 Million | 2.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $862.00K | 0.1% |
Asset Composition Trend (2013–2025)
This chart illustrates how iRhythm Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of iRhythm Technologies Inc.
Key Asset Composition Facts
- Current vs. Non-Current Assets: iRhythm Technologies Inc's current assets represent 68.9% of total assets in 2025, a decrease from 88.5% in 2013.
- Cash Position: Cash and equivalents constituted 23.1% of total assets in 2025, down from 53.5% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 6.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 7.4% of total assets.
iRhythm Technologies Inc Competitors by Total Assets
Key competitors of iRhythm Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO
|
USA | $9.79 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
iRhythm Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.17 | 5.71 | 4.60 |
| Quick Ratio | 4.98 | 5.58 | 4.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $548.81 Million | $524.67 Million | $262.55 Million |
iRhythm Technologies Inc - Advanced Valuation Insights
This section examines the relationship between iRhythm Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 22.97 |
| Latest Market Cap to Assets Ratio | 3.57 |
| Asset Growth Rate (YoY) | 9.5% |
| Total Assets | $1.02 Billion |
| Market Capitalization | $3.65 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values iRhythm Technologies Inc's assets at a significant premium (3.57x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: iRhythm Technologies Inc's assets grew by 9.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for iRhythm Technologies Inc (2013–2025)
The table below shows the annual total assets of iRhythm Technologies Inc from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $1.02 Billion | +9.51% |
| 2024-12-31 | $931.45 Million | +115.04% |
| 2023-12-31 | $433.14 Million | -3.36% |
| 2022-12-31 | $448.22 Million | -3.18% |
| 2021-12-31 | $462.97 Million | -9.53% |
| 2020-12-31 | $511.74 Million | +67.12% |
| 2019-12-31 | $306.21 Million | +155.79% |
| 2018-12-31 | $119.71 Million | -10.08% |
| 2017-12-31 | $133.12 Million | -3.64% |
| 2016-12-31 | $138.16 Million | +264.80% |
| 2015-12-31 | $37.87 Million | +104.61% |
| 2014-12-31 | $18.51 Million | +39.55% |
| 2013-12-31 | $13.26 Million | -- |
About iRhythm Technologies Inc
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more